Russell Investments Group Ltd. Acquires 1,927 Shares of Encompass Health Co. (NYSE:EHC)

Russell Investments Group Ltd. increased its holdings in shares of Encompass Health Co. (NYSE:EHC) by 1.9% during the third quarter, HoldingsChannel reports. The firm owned 101,363 shares of the company’s stock after buying an additional 1,927 shares during the period. Russell Investments Group Ltd.’s holdings in Encompass Health were worth $7,661,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also made changes to their positions in EHC. Berman Capital Advisors LLC lifted its holdings in shares of Encompass Health by 75.1% during the second quarter. Berman Capital Advisors LLC now owns 788 shares of the company’s stock valued at $61,000 after purchasing an additional 338 shares in the last quarter. Maverick Capital Ltd. bought a new position in shares of Encompass Health during the second quarter valued at $73,000. Rockefeller Capital Management L.P. lifted its holdings in shares of Encompass Health by 377.1% during the second quarter. Rockefeller Capital Management L.P. now owns 1,002 shares of the company’s stock valued at $77,000 after purchasing an additional 792 shares in the last quarter. Private Capital Group LLC lifted its holdings in shares of Encompass Health by 23.4% during the third quarter. Private Capital Group LLC now owns 1,308 shares of the company’s stock valued at $99,000 after purchasing an additional 248 shares in the last quarter. Finally, Fifth Third Bancorp increased its position in Encompass Health by 265.2% during the third quarter. Fifth Third Bancorp now owns 1,366 shares of the company’s stock valued at $103,000 after acquiring an additional 992 shares during the last quarter. 90.21% of the stock is currently owned by hedge funds and other institutional investors.

NYSE:EHC opened at $65.86 on Friday. The company has a current ratio of 1.15, a quick ratio of 1.15 and a debt-to-equity ratio of 1.39. Encompass Health Co. has a 12-month low of $56.31 and a 12-month high of $89.68. The stock has a 50-day moving average price of $64.69 and a 200 day moving average price of $64.58. The stock has a market capitalization of $6.55 billion, a P/E ratio of 16.22, a P/E/G ratio of 0.74 and a beta of 1.02.

Encompass Health (NYSE:EHC) last released its earnings results on Wednesday, October 27th. The company reported $1.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.06 by ($0.03). Encompass Health had a return on equity of 19.87% and a net margin of 8.10%. The business had revenue of $1.28 billion for the quarter, compared to analysts’ expectations of $1.31 billion. During the same quarter in the prior year, the business posted $0.78 EPS. The business’s revenue for the quarter was up 9.4% compared to the same quarter last year. On average, research analysts predict that Encompass Health Co. will post 4.31 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, January 18th. Investors of record on Monday, January 3rd will be given a dividend of $0.28 per share. This represents a $1.12 annualized dividend and a dividend yield of 1.70%. The ex-dividend date of this dividend is Friday, December 31st. Encompass Health’s dividend payout ratio is currently 27.59%.

A number of research firms recently commented on EHC. Mizuho reduced their price objective on Encompass Health from $94.00 to $80.00 and set a “buy” rating for the company in a research report on Wednesday, November 3rd. UBS Group began coverage on Encompass Health in a research report on Thursday, September 23rd. They set a “buy” rating and a $98.00 price objective for the company. Raymond James reduced their price objective on Encompass Health from $107.00 to $90.00 and set a “strong-buy” rating for the company in a research report on Tuesday, November 2nd. Zacks Investment Research cut Encompass Health from a “buy” rating to a “hold” rating and set a $67.00 price objective for the company. in a research report on Tuesday, November 2nd. Finally, Truist Securities reduced their price objective on Encompass Health from $100.00 to $88.00 and set a “buy” rating for the company in a research report on Wednesday, October 13th. One equities research analyst has rated the stock with a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, Encompass Health currently has a consensus rating of “Buy” and a consensus price target of $88.30.

Encompass Health Company Profile

Encompass Health Corp. engages in the provision of post-acute healthcare services. It operates through the Inpatient Rehabilitation and Home Health and Hospice segments. The Inpatient Rehabilitation segment operates inpatient rehabilitation hospitals that provides rehabilitative treatment and care to patients who are recovering from stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions and amputations.

Further Reading: Straddles

Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Co. (NYSE:EHC).

Institutional Ownership by Quarter for Encompass Health (NYSE:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.